MariMed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	159.83	157.71	148.6	134.01	121.46
Revenue Growth (YoY)	1.34%	6.13%	10.89%	10.33%	138.66%
Cost of Revenue	101.95	95.1	82.68	70.05	55.2
Gross Profit	57.88	62.61	65.92	63.96	66.26
Selling, General & Admin	58.63	59.39	50.72	38.88	37.54
Operating Expenses	60.22	59.05	50.84	42.63	39.4
Operating Income	-2.33	3.56	15.08	21.33	26.86
Interest Expense	-7.5	-6.94	-9.19	-1.69	-2.36
Interest & Investment Income	0.18	0.11	0.27	0.96	0.11
Other Non Operating Income (Expenses)	0.08	0.1	-0.65	-0.05	-0
EBT Excluding Unusual Items	-9.58	-3.18	5.51	20.55	24.61
Merger & Restructuring Charges	-1.29	-0.95	-0.7	-0.96	-
Gain (Loss) on Sale of Investments	-	-0.15	-0.08	-0.08	-0.8
Gain (Loss) on Sale of Assets	-	-	-0.91	-	-
Other Unusual Items	-	-	-10.43	-	-
Pretax Income	-10.86	-4.27	-6.6	19.51	23.82
Income Tax Expense	3.59	8.16	9.41	5.89	16.19
Earnings From Continuing Operations	-14.46	-12.43	-16.01	13.61	7.62
Minority Interest in Earnings	-0.03	-0.04	-0.02	-0.15	-0.4
Net Income	-14.48	-12.47	-16.03	13.47	7.23
Net Income to Common	-14.48	-12.47	-16.03	13.47	7.23
Net Income Growth	-	-	-	86.41%	236.99%
Shares Outstanding (Basic)	390	379	363	338	326
Shares Outstanding (Diluted)	390	379	363	380	372
Shares Change (YoY)	2.90%	4.33%	-4.44%	2.12%	14.88%
EPS (Basic)	-0.04	-0.03	-0.04	0.04	0.02
EPS (Diluted)	-0.04	-0.03	-0.04	0.04	0.02
EPS Growth	-	-	-	99.41%	149.07%
Free Cash Flow	6.53	-5.18	-12.22	-4.83	17.98
Free Cash Flow Per Share	0.02	-0.01	-0.03	-0.01	0.05
Gross Margin	36.22%	39.70%	44.36%	47.73%	54.55%
Operating Margin	-1.46%	2.26%	10.15%	15.92%	22.12%
Profit Margin	-9.06%	-7.90%	-10.79%	10.05%	5.95%
Free Cash Flow Margin	4.08%	-3.28%	-8.22%	-3.60%	14.80%
EBITDA	9.18	14.42	23.65	26.04	29.65
EBITDA Margin	5.74%	9.14%	15.92%	19.43%	24.41%
D&A For EBITDA	11.51	10.86	8.57	4.71	2.79
EBIT	-2.33	3.56	15.08	21.33	26.86
EBIT Margin	-1.46%	2.26%	10.15%	15.92%	22.12%
Effective Tax Rate	-	-	-	30.21%	67.99%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.